Literature DB >> 7364320

Prednisolone absorption in acute colitis.

P R Elliott, J Powell-Tuck, P E Gillespie, J M Laidlow, J E Lennard-Jones, J English, J Chakraborty, V Marks.   

Abstract

Peak plasma levels were reduced after an oral dose of 40 mg prednisolone in six patients with severe acute colitis as compared with six normal subjects, though total absorption appeared to be similar; the findings suggest that prednisolone absorption was delayed in acute colitis. A dilutional fall in plasma albumin was observed in normal subjects and in the patients after 40 mg prednisolone by mouth.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7364320      PMCID: PMC1419558          DOI: 10.1136/gut.21.1.49

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  4 in total

1.  A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.

Authors:  J Chakraborty; J English; V Marks; M C Dumasia; D J Chapman
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.

Authors:  R G Henderson; T Wheatley; J English; J Chakraborty; V Marks
Journal:  Br Med J       Date:  1979-06-09

3.  Adrenal and clinical responses to corticotrophin and prednisone in inflammatory disease of the colon.

Authors:  M Friedman; J M Hinton; J E Lennard-Jones
Journal:  Gut       Date:  1969-03       Impact factor: 23.059

4.  A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.

Authors:  J Powell-Tuck; R L Bown; J E Lennard-Jones
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

  4 in total
  18 in total

Review 1.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis.

Authors:  Han Ho Jeon; Hyun Jung Lee; Hui Won Jang; Jin Young Yoon; Yoon Suk Jung; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 3.  Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

4.  Plasma levels and response to prednisolone therapy in rheumatoid arthritis.

Authors:  M De Silva; B L Hazleman; J Chakraborty; J English; V Marks
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

5.  Alteration of plasma prednisolone levels by indomethacin and naproxen.

Authors:  S A Rae; I A Williams; J English; E M Baylis
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

6.  Plasma prednisolone levels during intravenous therapy in acute colitis.

Authors:  L M Berghouse; P R Elliott; J E Lennard-Jones; J English; V Marks
Journal:  Gut       Date:  1982-11       Impact factor: 23.059

7.  Medical treatment of ulcerative colitis.

Authors:  Uma Mahadevan
Journal:  Clin Colon Rectal Surg       Date:  2004-02

Review 8.  Severe ulcerative colitis: at what point should we define resistance to steroids?

Authors:  Maria Esteve; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 9.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

10.  Effect of inflammatory bowel disease on absorption and disposition of prednisolone.

Authors:  R L Milsap; D E George; S J Szefler; K A Murray; E Lebenthal; W J Jusko
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.